IL103418A - Therapeutic agent for the t-cell mediated inflammation of the joints and its production - Google Patents

Therapeutic agent for the t-cell mediated inflammation of the joints and its production

Info

Publication number
IL103418A
IL103418A IL103418A IL10341892A IL103418A IL 103418 A IL103418 A IL 103418A IL 103418 A IL103418 A IL 103418A IL 10341892 A IL10341892 A IL 10341892A IL 103418 A IL103418 A IL 103418A
Authority
IL
Israel
Prior art keywords
joints
cell mediated
production
mediated inflammation
therapeutic agent
Prior art date
Application number
IL103418A
Other languages
English (en)
Other versions
IL103418A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215749A external-priority patent/GB9215749D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL103418A0 publication Critical patent/IL103418A0/xx
Publication of IL103418A publication Critical patent/IL103418A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2893—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD52
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL103418A 1991-10-15 1992-10-14 Therapeutic agent for the t-cell mediated inflammation of the joints and its production IL103418A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77559891A 1991-10-15 1991-10-15
GB929215749A GB9215749D0 (en) 1992-07-24 1992-07-24 Medicaments

Publications (2)

Publication Number Publication Date
IL103418A0 IL103418A0 (en) 1993-03-15
IL103418A true IL103418A (en) 1997-11-20

Family

ID=26301317

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103418A IL103418A (en) 1991-10-15 1992-10-14 Therapeutic agent for the t-cell mediated inflammation of the joints and its production

Country Status (12)

Country Link
EP (1) EP0610447B1 (de)
JP (1) JP3535155B2 (de)
KR (1) KR100264218B1 (de)
AT (1) ATE174515T1 (de)
AU (1) AU671807B2 (de)
CA (1) CA2120911A1 (de)
DE (1) DE69227918T2 (de)
DK (1) DK0610447T3 (de)
ES (1) ES2125977T3 (de)
IL (1) IL103418A (de)
MY (1) MY115415A (de)
WO (1) WO1993007899A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
GB9022543D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Antibody production
GB9603507D0 (en) * 1996-02-20 1996-04-17 Isis Innovation Antibody variants
GB2380127A (en) 2001-09-26 2003-04-02 Isis Innovation Treatment of chronic joint inflammation
BR112014029417B1 (pt) * 2012-05-25 2023-03-07 Cellectis Método ex vivo para a preparação de células t para imunoterapia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3121823B2 (ja) * 1988-02-12 2001-01-09 ビーティージー・インターナショナル・リミテッド 抗体におけるまたは抗体に関する改良
DE69028713T3 (de) * 1989-12-27 2004-05-13 Centocor, Inc. Schimäre immunoglobuline für cd4-rezeptoren
GB9022547D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Purified immunoglobulin

Also Published As

Publication number Publication date
KR100264218B1 (ko) 2000-08-16
JPH07500330A (ja) 1995-01-12
AU671807B2 (en) 1996-09-12
DE69227918T2 (de) 1999-05-12
CA2120911A1 (en) 1993-04-29
DK0610447T3 (da) 1999-08-23
DE69227918D1 (de) 1999-01-28
JP3535155B2 (ja) 2004-06-07
MY115415A (en) 2003-06-30
EP0610447B1 (de) 1998-12-16
AU2698592A (en) 1993-05-21
ATE174515T1 (de) 1999-01-15
IL103418A0 (en) 1993-03-15
ES2125977T3 (es) 1999-03-16
EP0610447A1 (de) 1994-08-17
WO1993007899A1 (en) 1993-04-29

Similar Documents

Publication Publication Date Title
MY111961A (en) Therapeutic method
DE69329621D1 (de) MONOKLONALE ANTIKöRPER GEGEN DEFINIIERTE REGIONEN DES T-ZELL-ANTIGENREZEPTORS
CA2146647A1 (en) Treatment of autoimmune and inflammatory disorders
CA2163032A1 (en) Antibody Fragments in Therapy
CA2429027A1 (en) Antibodies against human receptor h4-1bb
ZA949227B (en) Human monoclonal antibodies against human cytokines and methods of making and using such antibodes
EP1266965A3 (de) Rekombinante Antikörper zur humanen Therapie
FI861150L (fi) Monoklonala antikroppar mot metallkelat.
WO2003054018A3 (en) Anti-tirc7 antibodies in therapy of inflammatory diseases
IL103418A (en) Therapeutic agent for the t-cell mediated inflammation of the joints and its production
EP0340604A3 (en) Monoclonal antibody and its use
BG106226A (en) A blocking monoclinal antibody to vla-1 and its use for the treatment of inflammatory disorders
EP0396505A3 (de) Für einen Immunoglobulin-Isotyp spezifische monoklonale Antikörper
AU584690B2 (en) E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
GR3024907T3 (en) Antivenom immunesera
WO1994018988A3 (en) Use of heparins for the treatment of inflammatory or immunological diseases
ATE179214T1 (de) Antiidiotypische monoklonale antikörper gegen den lewis y-spezifischen monoklonalen antikörper br55-2 und deren verwendungen
AU4959193A (en) High affinity, strongly neutralizing monoclonal antibodies against the CD-4 binding site of GP120 of human immunodeficiency virus
AU6098994A (en) Methods and agents for the diagnosis and treatment of rheumatoid arthritis
ZA916313B (en) New use of a monoclonal antibody
CA2060384A1 (en) A pharmaceutical composition containing an antibody recognizing the cdw52 antigen
GEP20043233B (en) Composition Containing Blocking Monoclonal Antibody VLA-1
IL161872A (en) Antibody stimulating il-1ra production
RU93019973A (ru) Устройство для вибромеханической обработки осесимметричных деталей
MX9706130A (es) Uso de compuestos especificos de lck sh2 para tratar enfermedades autoinmunes y el rechazo de aloinjertos.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
HC Change of name of proprietor(s)
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired